Loading...
First Round of Abstract Submission Ends: Aug 30, 2026
Extended Early Bird Ends: Dec 28, 2025

Plenary Speakers

Prof. Reinhard Neubert
Martin-Luther-Universitat Halle-Wittenberg, Germany
Title: Perspective of nanotechnology in dermal and transdermal drug delivery
Will update soon.
Prof. Binghe Wang
Georgia State University, USA
Title: Developing Carbon Monoxide as a Therapeutic Agent: Overcoming A Challenging Drug Delivery Problem.
Dr. Binghe Wang is Regents’ Professor of Chemistry, Dr. Frank Hannah Chair in Medicinal Chemistry, Georgia Research Alliance Eminent Scholar in Drug Discovery, and founding Director of the Center for Diagnostics and Therapeutics at Georgia State University. He served as the Chemistry Department chair (2011-13), and associate dean (2014-2018) and interim dean (2016) of the College of Arts and Sciences. Dr. Wang is a fellow of the National Academy of Inventors, the Editor-in-Chief of Journal of Enzyme Inhibition and Medicinal Chemistry, and the founding serial editor of Wiley Series in Drug Discovery and Development.
Dr. Wang’s research covers drug design, drug delivery, chemosensing, chemical biology, and organic chemistry. He has co-authored over 370 papers with his students, postdocs and other collaborators, and has given about 270 invited lectures worldwide. Dr. Wang also served as the Editor-in-Chief of Medicinal Research Reviews for 20 years (2000-2019) and has participated in over 60 NIH review Study Section meetings and the organization of over 40 international symposia and conferences including serving as a lead co-chair of the 2026 National Medicinal Chemistry Symposium of the American Chemical Society.
Prof. Francesco Maione
University of Naples Federico II, Italy
Title: Blueprint mapping reveals a therapeutic window for dual IL-17A/F neutralization with a novel topical biologic (Ab-IPL-IL-17) in psoriasis
Prof. Maione's teaching and research activity is focused on i) the role of interleukin-17A/F (IL-17A/F) in the etiopathogenesis of autoimmune-based inflammatory diseases such as rheumatoid arthritis, immune colitis and psoriasis and ii) the role of natural compounds, nutraceuticals/novel foods and novel supplements in the regulation and modulation of the immune response. His research activity as head of the ISO9001-certified laboratory ImmunoPharmaLab, at the Department of Pharmacy, University of Naples Federico II, is also supported by active participation in several licensed clinical trials both in Italy and abroad (UK).
Prof. Gerd Schmitz
University Hospital Regensburg, Germany
Title: Human milk regulates stem cell fate decisions - Implications for the prevention of obesity and diabetes by breastfeeding in contrast to formula feeding
Professor Dr. med. Gerd Schmitz was Professor of Laboratory Medicine and Transfusion Medicine and the former Head of the Institute for Clinical Chemistry and Laboratory Medicine-Central Laboratory and Bloodbank/Stemcell-Center at the University Clinic of Regensburg.

The major research interest has been the pathogenesis of vascular and metabolic diseases with a focus on the role of the innate immune system and particularly cytomics of blood cells and their released microparticles. The group coordinated the EU-funded “European Working Group of Clinical Cell Analysis (EWGCCA)” with a major focus on Multiparameter Fluorescence Flow Cytometry and Confocal Imaging Microscopy.

The group was the first who published the genetic defects of the rare diseases Acid Lipase Deficiency(CESD & Wolmans Disease), ApoA-I Deficiency with Plane Xanthomas, and ABCA1 Deficiency(Tangier Disease). The group continued identifying new mutations in ABCA3 Deficiency, Ceroid Lipofuscinosis, Hermansky-Pudlack Syndrome and Sphingolipidoses. A core competence of the group was the development and implementation of new multiomics-technologies for liquid, cellular and molecular analyses towards evidence-based medicine. Later, a major focus was related to quantitative high-throughput mass-spectrometry (HT-MS/MS-based lipidomics. Here the group had a leading position in Europe, covering the major lipid classes and species. We coordinated the European FP-7-IP-Project LipidomicNet and were a member of the National BMBF-SysMBIO project. We also participated in the BMBF-DEEP (German Epigenome Project) & the EU-funded MyNewGut consortia. The group extensively characterized the human blood cell lipidome, proteome, transcriptome, and epigenome, especially in monocytes/ macrophages, platelets and circulating microparticles/exosomes. The group characterized the changes in the lipidomic, proteomic, and miRNA-composition of platelets and their microparticles during platelet senescence. The group contributed with lipidomics (e.g. tracking FA-species through miR-122 related lipid classes such as acylglycerols, glycerophospholipids, cholesterylesters, sphingolipids), and analysis of microparticle composition or quantity, and in vitro laboratory testing. Finally, the group studied the Influence of lipidomic and epigenetic stimuli on the in vitro differentiation of members of the “stem cell niche” towards hematopoietic-, osteogenic-, adipogenic- and fibrogenic-lineage development. Prof. Schmitz current interest focuses on the epigenetic, transcriptomic and lipidomic signaling of human milk and milk extracellular vesicles.

He published with his group more than 380 peer reviewed scientific publications in leading International Journals.
Prof. Ilkay Erdogan Orhan
Lokman Hekim University, Türkiye
Title: Unlocking the Therapeutic Potential of Phytochemicals Through Nanoformulations in Skin Aging
Prof. Dr. Ilkay Erdogan Orhan holds a pharmacist degree (1993) from Gazi University (Ankara, Türkiye), 1st M.Sc. degree from the Department of Pharmacognosy at the same Faculty (1996) with a young scientist scholarship provided by Scientific and Technological Research Council of Türkiye (TUBITAK). Then, she was awarded her second M.Sc. degree in Marine Natural Product Chemistry in 1998 at the University of the Ryukyus in Japan, supported by a Monbusho scholarship. She earned the Ph.D. degree in Pharmacognosy at the Faculty of Pharmacy, Gazi University (Ankara, Türkiye) in 2002. She was a post-doctoral researcher at the Department of Chemistry at the University of Winnipeg (Canada) in 2003 under the NATO-TUBITAK fellowship program. She was promoted to Assoc. Prof. position by the Higher Education Council (Türkiye) in 2004 and to full professor in 2009.

Dr. Orhan was appointed as Dean of the Faculty of Pharmacy at Eastern Mediterranean University in Northern Cyprus (2011-2014) and Dean of the Faculty of Pharmacy at Gazi University in Ankara, Türkiye (2016-2024). Currently, Dr. Orhan is Dean of the Faculty of Pharmacy at Lokman Hekim University in Ankara, Türkiye.

Dr. Orhan is European Managing Group Member of International Science Council (ISC), the principal member of the Turkish Academy of Sciences (TÜBA) and the Islamic World Academy of Sciences (IAS), and the vice president of the International Scientific Evaluation Board of the Austrian Drug Screening Institute (ADSI). She served as the Representative of Southeast Europe & Turkey Region for the Phytochemical Society of Europe (PSE) for 2019-2023. She is presently the Associate Editor of Phytomedicine (Elsevier, Q1).

Dr. Orhan received several awards such as Young Woman Scientist Award in Asia continent by OWSD (Organization of Women in Science in Developing Countries) & Elsevier, Science Award in Biology by COMSTECH (OIC Standing Committee on Science and Technological Cooperation) in 2010, Young Woman Scientist Award (in Life Sciences) by L’Oreal & Turkish Academy of Sciences in 2011, and Honor Award by Gazi University in 2011, Innovation Award for Women in Turkey in 2015, Science Award by Turkish Association of Pharmacists in 2016, Golden Mortar Science Award in Pharmacy in 2017, Silver Medal for Patent in International Invention Fair by Turkish Ministry of Science and Technology in 2017 as well as Best Academic Invention Medal by International Federation of Invention Associations (IFIA) in 2018. She also received the TWAS (The World Academy of Sciences) Science Award in Chemistry (2024), Science Award by Istanbul Technical University (2024), Certificate of Outstanding Service and Achievement from the Turkish Industrialists and Businessmen's Foundation (TÜSİAV) (2024) and Climate Ambassador Award (2024) by the Turkish Vegan and Healthy Life Tourism Association (TEVSAD) & Turkish Industrialists and Businessmen Foundation (TÜSİAV) & Ministry of Environment and Urbanization.

Dr. Orhan is currently the author of 324 scientific papers listed by SCI-E, 46 articles in other scientific journals, 28 book chapters, 4 patents (Turkish, US, & EP), 6 patent applications, and 3 books. Her h index is 61 (Web of Science) and 61 (SCOPUS) with 20600 citations. Her research interests are pharmacognosy, phytotherapy, phytochemistry and bioactivities of natural products, natural cosmetics, sports pharmacy, and aromatherapy.
Prof. Jianbo Xiao
University of Vigo, Spain
Title: Polypehnols Reshape Metabolic-Epigenetic Interplay to Induce Transgenerational Host Defense
Dr. Jianbo Xiao is current a full professor of Department of Analytical Chemistry and Food Science, Faculty of Science, University of Vigo (Spain) and the distingished professor of Universidad Europea del Atlántico (Spain). He received PhD degree in nutrition from Okayama Prefectural University (Japan) in 2009. He worked as a Postdoc supported by AvH foundation at University of Würzbug, Germany (April 2013-May 2015) and then worked as an assistant professor in University of Macau (October 2015-December 2020). He has accepted and published more than 500 peer reviewed papers including Nature Reviews Drug Discovery, Nature Communication, Advanced Science, Journal of Advanced Research, Pharmacological Research, Food Chemistry, and so on (Google citation: 50000, H-index 113). Dr. Xiao is the expert Reviewer of European Science Foundation, UK Diabetes Foundation (UK), Natural Science Foundation of China (China), the Italian Ministry for Education, University and Research (Italy), Poland National Science Centre (Poland), National Center of Science and Technology Evaluation (Kazakhstan), and Croatian Science Foundation (Croatia). Dr. Xiao is the founding editor of Food Frontiers (IF 6.9), eFood (IF 5.7), Food Safety and Health (Wiley), and Future Postharvest and Food (Wiley), the associate editor of Journal of Advanced Research (IF 13.0), Phytomedicine (IF 8.3), Phytochemistry Reviews (IF 7.6), Quality Assurance and Safety of Crops & Foods (IF 5.3), Journal of Berry Research (IF 1.5), and Phytomedicine Plus (Elsevier), the academic editor of Journal of Food Biochemistry (IF 4.0) & Journal of Food Processing and Preservation (IF 2.5), the section editor of Current Neuropharmacology (IF 5.3), and the editorial board member of Trends in Food Science & Technology (IF 15.4), Critical Reviews in Food Science and Nutrition (IF 12.0), Current Research in Food Science (IF 7.0), Food Science and Human Wellness (IF 7.4), Current Research in Biotechnology (IF 4.0), Industrial Crops and Products (IF 6.2), Journal of Nutritional Biochemistry (IF 4.9), Food Chemistry: Molecular Sciences (IF 4.7), and so on.
Prof. Xueji Zhang
Shenzhen University, China
Title: Emerging Frontiers in Anti cancer drug from natural meficin
Will update soon.
Dr. Ren-You Gan
Hong Kong Polytechnic University, Hong Kong SAR, China
Title: Chinese Tea: From the Chemistry to Health Functions
Dr. GAN, Renyou is currently an Assistant Professor & Presidential Young Scholar at the Department of Food Science and Nutrition, The Hong Kong Polytechnic University, Hong Kong SAR, China. He received his medical bachelor degree from Sun Yat-Sen University (SYSU), China, and Ph.D. degree from the University of Hong Kong (HKU). He was previously an Assistant Professor at Shanghai Jiao Tong University (SJTU), a Chief Scientist at the Institute of Urban Agriculture (IUA), Chinese Academy of Agricultural Sciences (CAAS), a Principal Scientist at Singapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR), Singapore, and an Adjunct Assistant Professor at National University of Singapore (NUS).

His research mainly focuses on plant-based foods, food functional ingredients, probiotics, gut microbiome and human nutrition/health. His related work has generated more than 250 SCI publications, including more than 140 papers as the first/corresponding author and 31 ESI highly cited papers (data retrieved from WOS in Dec 2025). He has also filed more than 30 patents, with 20 of them awarded. According to Google Scholar, his publications have been cited more than 28,700 times, with an H-index of 89. He serves as the editorial board member of several international journals, including Food as Medicine (Editor-in-Chief), iMeta (Executive Associate Editor), iMetaOmics (Executive Editor), Current Research in Biotechnology (Executive Editor), Fermentation (Section Editor-in-Chief), Frontiers in Nutrition (Section Associate Editor), Nutrients/Antioxidants/Foods/npj Science of Food/Discover Food (Editorial Board members). He has been listed in the Clarivate “Highly Cited Researcher” (Agricultural Sciences, 2021-2023), the Stanford University “World Top 2% Scientists” (Food Science, 2020-2025), ScholarGPS “Highly Ranked Scholar-Prior Five Years” (Agriculture and Natural Resources, 2022-2025), Scilit “Top Cited Scholar” (Phytochemicals and Food Science & Technology, 2023-2025), and the Research.com “Best Biology and Biochemistry Scientists” (2024-2025).